Drug Topics

JULY 15, 2024

Updated vaccines are expected to be available in the coming months.

Vaccines 212

Vaccines 212

STAT

JULY 15, 2024

Bird flu snapshot: This is the latest installment in a series of regular updates on the H5N1 flu outbreak in dairy cows that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. There are more human cases of H5N1 bird flu infection, and another state has joined the list of those with infected dairy cow herds.

145

145

Pharmacy Times

JULY 15, 2024

The findings demonstrate that the mG900 region plays a significant role in Type-2 helper T (Th2) cell differentiation and enhances allergic airway inflammation.

139

139

STAT

JULY 15, 2024

WASHINGTON – Top Food and Drug Administration officials met multiple times earlier this year to discuss the regulation of ultra-processed foods, according to internal agency calendars obtained by STAT. Two FDA officials, Haider Warraich and Robin McKinnon, met multiple times in February to discuss regulating these edible industrial creations, such as sodas, prepackaged cookies, and most breakfast cereals.

Documentation 145

Documentation FDA 145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JULY 15, 2024

A new study released by healthcare AI company Atropos found that general purpose LLMs like ChatGPT, Claude and Gemini are not fit for use in clinical decisionmaking. | Healthcare AI company Atropos conducted a study to test how reliably ChatGPT, Claude, Gemini, OpenEvidence and its own model, ChatRWD, answer clinicians' questions. General use LLMs did not fare well.

134

134

Fierce Pharma

JULY 15, 2024

While patent cliffs are looming for many of biopharma’s top-selling products, the industry has enormous capacity to respond as “conditions for M&A are favorable,” according to a research note f | While patent cliffs loom for many of biopharma’s top-selling products, the industry has enormous capacity to respond as “conditions for M&A are favorable,” according to a July 11 research note from Morgan Stanley.

142

142

STAT

JULY 15, 2024

WASHINGTON — There’s been a long lull in fighting between primary care and specialty doctors over how much they get paid by Medicare, but that truce might not last if Congress overhauls the system that determines physician payment. This year, Congress began considering changes to the Medicare physician pay system for the first time since creating the current version in 2015.

137

137

Fierce Pharma

JULY 15, 2024

It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become increasingly popular in recent years. | It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become increasingly popular in recent years. Now, the FDA is proposing to work directly with industry through a series of facility tours that could enable both sides to learn something from each other.

FDA 127

FDA 127

Fierce Healthcare

JULY 15, 2024

A Chicago safety-net hospital’s former chief financial officer and chief transformation officer have been charged for their alleged roles in a scheme to embezzle over $15 million from the nonprofit | Loretto Hospital's chief financial officer as well as its chief transformation officer allegedly authorized payments for bogus vendor goods and services.

Hospitals 118

Hospitals 118

Drug Topics

JULY 15, 2024

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

112

112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JULY 15, 2024

The Federal Trade Commission (FTC) has opened a probe into the country’s two largest dialysis care providers and the terms of their contracts with physicians, according to a weekend report that has | A DaVita representative described a weekend report of the probe as "old news" and "not something that we feel like there’s an enormous amount of stress over.

116

116

Fierce Pharma

JULY 15, 2024

CAR-T specialist Legend Biotech has reportedly received a takeover bid and has tapped Centerview Partners as a financial adviser to evaluate its options, StreetInsider

115

115

Fierce Healthcare

JULY 15, 2024

The Centers for Medicare & Medicaid Services (CMS) released an audit showing Aetna Health of Texas miscalculated a key metric and was not following federal guidelines as set out by the No Surpr | The first No Surprises Act audit of health plans found significant errors in how Aetna Health of Texas calculated the qualifying payment amount for air ambulance services.

114

114

STAT

JULY 15, 2024

The messaging around mammography often doesn’t go beyond this simple three-word refrain: screening saves lives. Medical groups have also moved toward earlier breast cancer screening: The United States Preventive Services Task Force, for example, earlier this year recommended that all women begin screening mammography at age 40. And yet, more women prefer to wait until age 50 to begin screening after learning about breast cancer screening’s benefits and drawbacks, according to a stu

131

131

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JULY 15, 2024

After two decades headquartered in the West London suburb of Brentford, GSK is officially coming home to central London. | After two decades headquartered in the West London suburb of Brentford, GSK's new digs are officially open and will house 3,000 workers in London's Knowledge Quarter.

119

119

STAT

JULY 15, 2024

One of the makers of Casgevy — the world’s first CRISPR-based medicine —  filed a lawsuit Monday intended to clear the way for the company to pay for fertility preservation services and treatment for people receiving the therapy, which can interfere with reproduction.  In the lawsuit, Vertex Pharmaceuticals challenged an oral opinion issued by the Health and Human Services Office of the Inspector General that its fertility support program would violate federal anti

133

133

The Checkup by Singlecare

JULY 15, 2024

Oxygen is essential to life—just three to six minutes without oxygen can cause brain damage or even death. Your blood oxygen level, or the amount of oxygen circulating in the blood, can be an indicator of your overall wellness. You can even measure your blood oxygen level at home with a device called a pulse oximeter. The device is placed on a finger (a toe or earlobe may also be used) and uses a light to measure your oxygen saturation.

Immunization 101

Immunization Vaccines Hospitals 101

STAT

JULY 15, 2024

Lexeo Therapeutics said Monday that a gene therapy designed to prevent fatal cardiac complications of a genetic disorder called Friedrich’s ataxia reduced signs of heart disease in a handful of patients. The data are very early and less-than-clear-cut. But given a top Food and Drug Administration official’s recent efforts to advance gene therapies under accelerated approval — most notably, with the decision to expand approval for Sarepta’s Duchenne muscular dystrophy

123

123

Pharmacy Times

JULY 15, 2024

After failure with methotrexate, treatment with leflunomide is typically recommended, but treatment with biosimilars could have greater quality-adjusted life years.

106

106

Outsourcing Pharma

JULY 15, 2024

When she was a teenager, Dr Jasmina Jankicevic wanted to research and promote better ways for children and adults to stay healthy, or regain health and well-being.

91

91

STAT

JULY 15, 2024

Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the Inflation Reduction Act. Unfortunately, the Centers for Medicare and Medicaid Services is interpreting the law in a way that will discourage companies from finding new uses — sometimes lifesaving new uses — for existing drugs. It will also deter companies from doing research on existing medicines to create improved versions that are more effective and have fewer side effects.

Hospitals 126

Hospitals 126

Pharmacy Times

JULY 15, 2024

Consumer-wearable devices can monitor treatment response and provide continuous health data for patients with heart disease and atrial fibrillation.

132

132

pharmaphorum

JULY 15, 2024

Framework governing early-stage clinical trials in the UK is stifling research and needs to be simplified, says BJCP paper

110

110

STAT

JULY 15, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday.  Just you, a beach chair, and Medicare regs Medicare dropped its own summer reading list last week — a tidy 3,200 pages of regulations that govern how  doctors , surgery centers, and  hospital outpatient departments will get paid next year.

Hospitals 118

Hospitals 118

Pharmacy Times

JULY 15, 2024

Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.

132

132

Drug Topics

JULY 15, 2024

Patients with acne who adhered to a mediterranean diet and supplemented with omega-3s saw improvements in inflammatory and non-inflammatory lesions.

112

112

Pharmacy Times

JULY 15, 2024

The 2024 American Society. ofClinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, highlighted significant advancements across various oncology disciplines.

123

123

Pharmaceutical Technology

JULY 15, 2024

AstraZeneca has obtained Health Canada’s Notice of Compliance (NOC) for Tagrisso (osimertinib) to treat NSCLC.

114

114

STAT

JULY 15, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning! Today, we look at some promising, but early, gene therapy data from Lexeo Therapeutics, examine Medicare’s new price negotiation rules and their impact on innovation, and more.

FDA 120

FDA 120

pharmaphorum

JULY 15, 2024

Germany inches closer to confidential pricing for patented medicines, with passage of Medical Research Act

113

113

Pharmaceutical Commerce

JULY 15, 2024

A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.

98

98

pharmaphorum

JULY 15, 2024

Two investment funds have decided to contest Taisho Pharma’s recently announced management buyout plan in court

102

102

Fierce Pharma

JULY 15, 2024

To receive Vertex and CRISPR Therapeutics’ $2.2 million gene therapy Casgevy for sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), patients must first undergo chemotherapy | Vertex has filed a lawsuit in federal court in Washington, D.C. against the U.S. Department of Health and Human Services (HHS) seeking to overturn the “erroneous legal positions” of the agency’s Office of the Inspector General (OIG).

Chemotherapy 68

Chemotherapy 68

pharmaphorum

JULY 15, 2024

An experimental gene therapy developed by Lexeo Therapeutics has shown early promise in treating one of the most serious complications of rare neurodegenerative disorder Friedreich's ataxia (FA).In a phase 1/2 SUNRISE-FA trial, the LX2006 therapy showed a reduction in cardiomyopathy – the most common cause of death in FA – in an initial group of patients with enlarged hearts at the start of the trial.

80

80